We are aware of phishing emails targeting speakers of events whose names appear on our events pages. If you are unsure if an email regarding event registration or accommodation has come from us please contact us and do not provide any credit card details or personal information
Share:
Development of Type 2 Diabetes Mellitus Drugs: State of the Art Cardiovascular Safety Assessments
5 - 6 October 2010, Washington DC, United States
Introduction
Interact with Senior FDA Members to Explore Emerging Issues in Cardiovascular Safety and Diabetic Drug Development Event Code: 10035
Venue
L’Enfant Plaza Hotel
L’Enfant Plaza Hotel, Washington DC, United States